McDonald's Corporation

New York Stock Exchange
Back to all articles
Somewhat Bearish -25

Here's Jim Cramer's advice on McDonald's stock after its third downgrade in a week

📉 Redburn Atlantic downgraded McDonald's to a sell rating with a price target of $260, implying nearly 15% downside from Monday's close.

💊 Analysts at Redburn argue GLP-1 weight loss drugs represent an underappreciated long-term threat by suppressing appetite and changing consumer behavior.

📈 Jim Cramer advises investors to buy the stock, stating that McDonald's will shrug off these downgrades and that the company is difficult to downgrade permanently.

🍗 Loop Capital lowered its price target to $315 due to negative customer feedback on a new chicken strip launch and concerns over traffic among lower-income consumers.

📉 Morgan Stanley cut its rating to hold-equivalent, reducing the price target slightly from $329 to $324.

👔 CEO Chris Kempczinski is praised by Cramer for his willingness to kill underperforming products rather than forcing them on franchisees.

📊 McDonald's shares fell 1.3% on Tuesday morning as investors digested the aggressive bearish call from Redburn Atlantic.

📉 The stock has lost approximately 4% in June, contrasting with a nearly 2% gain for the S&P 500 over the same stretch.

Bullish Signals
  • Jim Cramer views the recent downgrades as a buying opportunity, suggesting the market is underrating McDonald's ability to navigate challenges.
  • Cramer praises CEO Chris Kempczinski for his agility and willingness to course-correct or kill products that do not sell well.
  • Cramer believes it is difficult to predict when McDonald's fortunes will turn around, implying strong underlying resilience.
Risk Factors
  • Redburn Atlantic slashed the rating to sell with a price target of $260, citing GLP-1 weight loss drugs as a significant long-term threat to sales.
  • Loop Capital lowered its price target to $315 due to concerns that same-store sales growth may not rebound in 2025 following softening traffic among lower- and middle-income consumers.
  • Analysts at Loop Capital expressed concern over negative customer feedback on the recent chicken strip launch, which could impact the upcoming snack wrap introduction.
  • Morgan Stanley cut its rating to hold-equivalent, lowering the price target from $329 to $324.
  • McDonald's shares slipped 1.3% and have lost around 4% in June as investors reacted to the wave of downgrades.
Full Analysis
McDonald's stock faced significant pressure this week after receiving a third analyst downgrade in less than seven days. Redburn Atlantic recently slashed its rating to sell from buy, lowering the price target to $260 from $319, citing concerns that GLP-1 weight loss drugs are suppressing customer appetites and altering long-term demand dynamics. Jim Cramer of CNBC dismissed these bearish views as a buying opportunity, arguing that investors are underrating the company's resilience. He specifically praised CEO Chris Kempczinski for his ability to course-correct quickly if new product launches fail, noting that management will not force unsuccessful items on franchisees despite market pressure. Other analysts have also turned cautious, with Morgan Stanley and Loop Capital cutting their ratings to hold-equivalent status. Loop Capital lowered its price target to $315, expressing worry about softening traffic among lower- and middle-income consumers and citing negative feedback on a recent chicken strip launch as a potential precursor to issues with upcoming menu items. Shares of McDonald's slipped 1.3% following the Redburn downgrade, contributing to roughly 4% losses for the stock in June, while the broader S&P 500 gained nearly 2% during the same period. The consensus among analysts centers on whether the company can navigate product execution risks and shifting consumer habits driven by weight-loss medication trends.